-

Northlane Capital Partners Announces Promotion and Addition of Director of Business Development

BETHESDA, Md.--(BUSINESS WIRE)--Northlane Capital Partners (“NCP”), a middle market private equity firm focused on key segments within the healthcare and business services sectors, announced today the promotion of JJ Carbonell to Principal and the addition of Rich Grant as Director of Business Development.

Mr. Carbonell joined in 2013 and is involved in all aspects of NCP’s investment activity. His current investments include VMG Health, Brandmuscle, and Firma Clinical Research, and his realized investments include Science Care, Advarra, and Avalon Laboratories. He began his career as an analyst in the Leveraged Finance Group at Wells Fargo Securities. Mr. Carbonell received a B.S. in Business Administration from Washington & Lee University.

“JJ has been a key member of our firm since he joined eight years ago,” said Sean Eagle, Partner at NCP. “We are proud to promote JJ to a leadership role, after many years of contributing tremendous value to the NCP team and our portfolio companies.”

Mr. Grant brings over 15 years of sales, marketing, and business development experience with private equity related companies, including Growth Operators and SourceMedia. Mr. Grant is also Co-Chair of the Diversity, Equity, and Inclusion Task Force for the Association for Corporate Growth. He received a B.A. from Colgate University. In this newly created role, Mr. Grant will work jointly with the investment team on marketing and investment sourcing activities.

“We are excited to have Rich join NCP as Director of Business Development,” said Justin DuFour, Partner at NCP. “His experience and network will significantly enhance NCP’s sourcing efforts related to investment opportunities and operating executive talent. His addition will allow the NCP investment teams to prioritize engagement with prospects in targeted segments within the healthcare and business services sectors.”

About Northlane

Based in Bethesda, MD, NCP is a middle market private equity firm focused on key segments within the healthcare and business services sectors, where its principals have invested more than $1.5 billion of equity capital. NCP’s strategy is to partner with industry leading companies and great management teams, aligning incentives to accelerate growth and build value. NCP was recently named to Inc.'s 2020 Private Equity 50 list of the top founder-friendly private equity firms. For more information, please visit www.northlanecapital.com.

Contacts

Justin DuFour, Partner
(301) 841-1375

Northlane Capital Partners


Release Versions

Contacts

Justin DuFour, Partner
(301) 841-1375

Social Media Profiles
More News From Northlane Capital Partners

Northlane Capital Partners Announces Investment in File & ServeXpress

IRVING, Texas--(BUSINESS WIRE)--Northlane Capital Partners (“NCP”) announced today that it has completed an investment in File & ServeXpress (“FSX” or the “Company”), a leading provider of online document exchange, data and document management, and notifications, serving courts, government agencies, and legal professionals across the United States. NCP invested alongside the FSX management team, led by CEO Tammy Carter, underscoring a shared vision for the Company’s future. FSX provides a c...

SAI MedPartners Enhances Its Competitive Intelligence Capabilities Through the Acquisition of The Dunn Group

READING, Pa.--(BUSINESS WIRE)--SAI MedPartners (“SAI”), a global consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries, is pleased to announce that it has acquired The Dunn Group (“TDG”). Northlane Capital Partners (“NCP”) partnered with management to acquire SAI in June 2022. TDG, headquartered in Totowa, NJ, is a competitive intelligence firm that focuses on providing primary business intelligence to clients in the pharmaceu...

Northlane Capital Partners Announces Final Close of Oversubscribed Fund III at $750 Million

BETHESDA, Md.--(BUSINESS WIRE)--Northlane Capital Partners (“Northlane” or “NCP”) announced today the final closing of its oversubscribed third private equity fund, Northlane Capital Partners III LP (“NCP III” or “Fund III”), at its hard cap of $750 million. The total raised substantially surpassed Fund III’s $550 million target and reflects notable growth from its $408 million predecessor. Global investors include pension funds, insurance companies, endowments and foundations, asset managers,...
Back to Newsroom